OTTAWA (Reuters) - Canada has asked Swiss drug maker Roche AG to warn consumers of possible health risks linked to its influenza drug Tamiflu, the health department said on Wednesday.
Ottawa took the step after receiving international reports of side-effects such as hallucinations and abnormal behavior, including self-harm. The reports include cases involving children and teenagers, primarily in Japan.
"Health Canada has requested that the manufacturer ... update the Canadian prescribing information for Tamiflu to include this new information," the department said in a statement.
According to Health Canada, there have been 84 reports as of November 11 of Canadian patients having adverse effects when using Tamiflu. Ten of those cases involved fatalities...
1 comment:
To my mind one and all ought to look at this.
Post a Comment